I’ll keep it short and sweet. This is a biotech stock that has a pending FDA approval for May 24th. It’s currently at $19 and post-approval I think it’s going +$30.
I’ll keep it short and sweet. This is a biotech stock that has a pending FDA approval for May 24th. It’s currently at $19 and post-approval I think it’s going +$30.